Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Louisville, Ky.-based Humana contracted with Madison, Wis.-based Exact Sciences Corp. to cover Cologuard — a colon cancer test — as an in-network service for its members.

Here are four updates on gastroenterology and endoscopy companies. London-based Lumendi received 510(k) clearance from the FDA for its DiLumen, an endoscopic accessory. Laval, Quebec-based Valeant ...

Fact checked by Nick Blackmer Cologuard is getting an upgrade soon. An updated at-home screening test, called Cologuard Plus, is expected to be available in June 2025. Cologuard Plus is a more ...

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced the U.S. Food and Drug Administration approved the Cologuard Plus™ test, the company’ s next ...

Cologuard Plus: 93.9% (95% CI, 87.1-97.7) sensitivity for colorectal cancer; 43.4% (95% CI, 41.3-45.6) sensitivity for advanced precancerous lesions; ...

In average-risk adults, Cologuard Plus demonstrated sensitivities of 95% for CRC and 43% for advanced precancerous lesions at 94% specificity in the pivotal BLUE-C trial.